William Lawler

2.1k total citations
17 papers, 135 citations indexed

About

William Lawler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, William Lawler has authored 17 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in William Lawler's work include Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Advanced Breast Cancer Therapies (2 papers). William Lawler is often cited by papers focused on Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Advanced Breast Cancer Therapies (2 papers). William Lawler collaborates with scholars based in United States, United Kingdom and France. William Lawler's co-authors include Shaker R. Dakhil, Fadi Braiteh, Guy N. Rutty, Martin Reck, Fabrice Barlési, William G. Paxton, Wolfgang Schütte, Delia Alvarez, Enriqueta Felip and T. E. Lowe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

William Lawler

15 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Lawler United States 7 69 59 43 20 19 17 135
Sara Manglaviti Italy 7 72 1.0× 59 1.0× 28 0.7× 28 1.4× 14 0.7× 23 136
Nieves Martínez Lago Spain 8 121 1.8× 51 0.9× 40 0.9× 33 1.6× 18 0.9× 44 165
Benjamin Shum United Kingdom 4 92 1.3× 39 0.7× 36 0.8× 27 1.4× 12 0.6× 6 140
László Landherr Hungary 8 122 1.8× 62 1.1× 42 1.0× 61 3.0× 13 0.7× 20 191
Yan-Fang Ye China 7 76 1.1× 44 0.7× 21 0.5× 28 1.4× 29 1.5× 7 167
C. Ang Canada 4 25 0.4× 39 0.7× 47 1.1× 12 0.6× 12 0.6× 5 107
Rocco Giannicola Italy 8 99 1.4× 62 1.1× 34 0.8× 17 0.8× 13 0.7× 16 196
Kengo Kanayama Japan 7 45 0.7× 63 1.1× 61 1.4× 33 1.6× 25 1.3× 10 160
Luisa Piccin Italy 5 167 2.4× 69 1.2× 30 0.7× 18 0.9× 11 0.6× 16 219

Countries citing papers authored by William Lawler

Since Specialization
Citations

This map shows the geographic impact of William Lawler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Lawler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Lawler more than expected).

Fields of papers citing papers by William Lawler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Lawler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Lawler. The network helps show where William Lawler may publish in the future.

Co-authorship network of co-authors of William Lawler

This figure shows the co-authorship network connecting the top 25 collaborators of William Lawler. A scholar is included among the top collaborators of William Lawler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Lawler. William Lawler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lawler, William, et al.. (2025). Impact of obesity on the CCR6-CCL20 axis in epidermal γδ T cells and IL-17A production in murine wound healing and psoriasis. The Journal of Immunology. 214(1). 153–166. 1 indexed citations
2.
Chiu, Joanne, Ulka N. Vaishampayan, Rohit Joshi, et al.. (2023). 698 Safety and tolerability of magrolimab in combination with taxanes in patients with solid tumors. SHILAP Revista de lepidopterología. A792–A793.
3.
Hurvitz, Sara A., David W. Chan, Thomas J. Lomis, et al.. (2022). TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.. Journal of Clinical Oncology. 40(16_suppl). TPS623–TPS623. 21 indexed citations
4.
Goldman, Jonathan W., Amy L. Cummings, Melody Mendenhall, et al.. (2022). Primary analysis from the phase 2 study of continuous talazoparib (TALA) plus intermittent low-dose temozolomide (TMZ) in patients with relapsed or refractory extensive-stage small cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. 40(16_suppl). 8517–8517. 13 indexed citations
5.
Mok, Tony, William Lawler, Shaker R. Dakhil, et al.. (2021). KRYSTAL-12: A randomized phase 3 study of adagrasib (MRTX849) versus docetaxel in patients (pts) with previously treated non-small-cell lung cancer (NSCLC) with KRASG12C mutation.. Journal of Clinical Oncology. 39(15_suppl). TPS9129–TPS9129. 23 indexed citations
6.
Cummings, Amy L., Melody Mendenhall, Andrew Nguyen, et al.. (2021). Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ).. Journal of Clinical Oncology. 39(15_suppl). 8564–8564. 2 indexed citations
7.
Nolan, Jerry P., Jasmeet Soar, Nathaniel R.B. Cary, et al.. (2020). Compression asphyxia and other clinicopathological findings from the Hillsborough Stadium disaster. Emergency Medicine Journal. 38(10). 798–802. 6 indexed citations
8.
Noor, Zorawar S., Jonathan W. Goldman, William Lawler, et al.. (2019). Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer. Lung Cancer. 135. 104–109. 10 indexed citations
9.
Wakelee, Heather A., Zanete Zvirbule, Filippo de Braud, et al.. (2016). Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 18(1). 50–59. 34 indexed citations
10.
Salles, Gilles, Thomas J. Ervin, Robert Dichmann, et al.. (2014). A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with rituximab for previously treated indolent non-Hodgkin lymphomas (iNHL).. Journal of Clinical Oncology. 32(15_suppl). TPS8620–TPS8620. 1 indexed citations
11.
12.
Lawler, William, et al.. (2009). Walk and Die: An Unusual Presentation of Head Injury. Journal of Forensic Sciences. 54(6). 1466–1469. 5 indexed citations
13.
Lawler, William, et al.. (2000). Saturn V structural dynamic test/modeling. 41st Structures, Structural Dynamics, and Materials Conference and Exhibit. 1 indexed citations
14.
Lawler, William. (1990). Chronic Extradural Haemorrhage. American Journal of Forensic Medicine & Pathology. 11(1). 74–78. 1 indexed citations
15.
Lawler, William, Ahmed Ali, & William J. Hume. (1987). Essential pathology for dental students. Churchill Livingstone eBooks.
16.
Martin, Susan, et al.. (1986). LATE CELLULAR REJECTION IN RENAL TRANSPLANT RECIPIENTS. Transplantation. 41(2). 262–263. 7 indexed citations
17.
Lawler, William. (1981). Experimental mesangial proliferative glomerulopathy. The Journal of Pathology. 133(2). 107–122. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Manglaviti Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Benjamin Shum Breakdown of academic impact, for papers by László Landherr Breakdown of academic impact, for papers by Yan-Fang Ye Breakdown of academic impact, for papers by C. Ang Breakdown of academic impact, for papers by Rocco Giannicola Breakdown of academic impact, for papers by Kengo Kanayama Breakdown of academic impact, for papers by Luisa Piccin
Rankless by CCL
2026